Altadis was created in 2015 as the result of a joint venture between the Tecnimede Group and the Colombian company Altea Farmacêutica.
Altadis is committed to working at the forefront of the latest advances in healthcare technology and pharmaceuticals related to the central nervous system, cardiology, oncology, immunomodulators, and biotechnology.
Altadis has recently expanded its sales team to provide better coverage across Portugal. This achievement is aligned with Altadis' goal of becoming recognised as one of the top five best laboratories within the relevant markets by marketing at least five different therapeutic product ranges.
Altadis hopes to continue to expand in the Colombian pharmaceutical market in the coming years, through the development of new molecules (designed and manufactured within the Tecnimede Group), as well as through investment in new areas, such as primary care.
Altadis is presently formed of a team of committed professionals with a strong sense of belonging. It is a professional team constantly looking for ways to improve, driven to successfully meet the needs of pharmacists, doctors, researchers, and society as a whole.
